Oura's IPO Could Value It at $16B. What That Means for You
I covered Pixel Watch 5’s pricing and its $9.99-a-month Gemini Coach subscription the night Google announced it. What I didn’t get to: the feature from that same August 12 Made by Google event that actually matters more. Health Guardian is a new suite inside the Google Health app that estimates insulin resistance and blood pressure trends from data your watch is already collecting — no glucose sensor, no blood pressure cuff, and critically, no subscription gate.
That last part is the story. Google spent real stage time on Gemini Coach and priced it separately from the hardware. Health Guardian, which is arguably the more clinically significant announcement of the two, ships free to anyone who already owns a qualifying device. Here’s what it does, how Google says it works, and where the “it’s not a medical device” fine print actually matters.
| Insulin Resistance Trends | Blood Pressure Trends | Sleep Breathing Quality | |
|---|---|---|---|
| What it does | Flags long-term metabolic strain patterns | Estimates BP trend direction, not a reading | Tracks overnight breathing variation |
| Devices | Pixel Watch 3, 4, 5 + Fitbit Air | Pixel Watch 3, 4, 5 | Broader device support |
| Rollout | This fall (September 2026) | This fall (September 2026) | Rolling out alongside |
| Subscription required | None | None | None |
| Replaces a medical test? | No — explicitly not diagnostic | No — not calibrated against a cuff | No |
Best for: Anyone who already owns a qualifying Pixel Watch or Fitbit Air and wants an early flag on metabolic or cardiovascular drift, for free. Skip if: You’re managing diagnosed hypertension or diabetes and need clinical-grade numbers — this isn’t that, and Google says so directly.
Health Guardian isn’t a single feature — it’s a suite Google folded into the same keynote where it introduced Pixel Watch 5’s Gemini layer, and it’s rolling out to hardware people already own, not just the new watch. Here’s the featured-snippet version, because this is what people are actually searching for:
Google is framing the first two as the headline. According to its own numbers, roughly 40% of adults don’t realize their insulin resistance is shifting until symptoms show up, and about six in ten people miss the point where their blood pressure starts trending higher. Whether that framing holds up to scrutiny is a separate question — but it’s the pitch.
Here’s the thing to get right before anyone panics or gets overly excited: there is no glucose sensor in the Pixel Watch 5. Nothing on your wrist is measuring blood sugar directly, continuously or otherwise. What Insulin Resistance Trends does instead is pull together several weeks of heart rate, HRV, SpO2, movement, sleep, and skin-temperature data and run it through a model looking for patterns that have historically correlated with insulin resistance in other people’s data. Then it delivers a monthly summary, not a daily number.
That’s a meaningfully different product than a continuous glucose monitor, and Google isn’t pretending otherwise. It’s closer to what a good trainer would notice about you over a season — sleep getting worse, resting heart rate creeping up, recovery slower than it used to be — except automated and running in the background year-round.
The model underneath this is Google’s SensorFM, described as pretrained on more than one trillion minutes of wearable data from five million consenting users across more than 100 countries and over 20 device models, according to Google’s own announcement. The insulin-resistance signal specifically was trained and validated on data from more than 100,000 individuals, per reporting on the announcement. Google says the validation work was published in Nature, benchmarked against standard clinical blood tests — that’s Google’s own characterization of the study, and I’d want independent replication before treating it as settled science, but it’s a more rigorous starting point than most wellness-app “AI insight” features bother with.
This is the feature most likely to get misunderstood, so let’s be precise. Blood Pressure Trends does not give you a number like “118/76” the way a cuff does. It watches pulse wave and motion data over time and tells you whether your blood pressure appears to be drifting up, drifting down, or holding steady. No cuff, no manual calibration step required to start using it.
That’s a genuinely different approach than Samsung’s Galaxy Watch blood pressure feature, which I tested back in April. Samsung’s version needs an actual cuff for initial calibration and then another cuff session every 28 days to stay accurate — the feature that’s supposed to replace your cuff still needs your cuff, forever. Google’s pitch with Blood Pressure Trends is the opposite bet: skip calibration entirely and only claim to detect direction, not absolute values. Lower ceiling, lower friction.
The underlying model here is something Google calls WavesFM, trained on billions of minutes of heart and movement data and validated through what Google describes as its Fitbit Hypertension Labs study across a diverse population. In one testing method Google has disclosed, the system compared seven days of PPG and accelerometer data from Pixel Watch 3 against continuous ambulatory blood pressure monitoring — the more rigorous reference standard for this kind of validation. I haven’t seen independent third-party testing yet, and given how new this is, I’d treat “trending up” alerts as a prompt to actually check your blood pressure properly, not as a diagnosis.
This is where I have to be direct, because this site exists partly to answer exactly this question every time a company ships a new health feature: what does it actually cost?
Nothing. Insulin Resistance Trends, Blood Pressure Trends, and Sleep Breathing Quality Trends all ship without a Google Health Premium requirement. That’s a real departure from how Google priced Google Health Coach on the Fitbit Air and Pixel Watch 5 — $9.99 a month or $99 a year for the AI coaching layer. Health Guardian sidesteps that entirely. Tom’s Guide framed it accordingly: a feature this substantial landing free, on hardware people already own going back to Pixel Watch 3, is not the norm for this category.
Compare that to what else is on the market. WHOOP’s Women’s Health Blood Panel costs $299 as a one-time purchase, on top of an already-required annual subscription. Samsung’s blood pressure feature is free but demands a physical cuff and monthly recalibration, which is its own kind of cost — in time, if not dollars. Google’s approach here undercuts both: free, and functional without any additional hardware. That doesn’t make it more accurate than either of those — accuracy and price are separate arguments — but on the pure “what does this cost me” question, Health Guardian is the best deal currently on a wrist.
Google’s own language on this is unambiguous, and worth quoting directly because it changes how you should treat the alerts: Health Guardian “is not intended to diagnose, mitigate, treat, or cure any disease,” and should not be used for diabetes management or medication decisions. That’s not boilerplate legal cover — it’s the actual operating boundary of the feature. If Health Guardian flags a trend, the correct response is booking an actual blood test or a real BP cuff reading, not adjusting insulin or blood pressure medication based on what your watch inferred from your sleep data.
This lines up with the wellness-versus-medical-device line the FDA’s January 2026 guidance drew around exactly this category. Trend features that avoid disease-specific claims get to ship without premarket clearance. Features that cross into diagnosis do not. Health Guardian is built to live squarely on the wellness side of that line, which is precisely why it can ship broadly and for free while things like ECG detection still require regulatory clearance. That’s not a criticism — it’s the reason this exists as a background monthly summary instead of a real-time medical alert.
Turn it on if: you already own a Pixel Watch 3, 4, 5, or a Fitbit Air, and you want a free, passive early-warning layer on top of data your watch is collecting anyway. There’s no downside cost here — it’s not gating anything else, and there’s no subscription attached to it.
Skip the anxiety spiral if: you’re prone to health anxiety around wearable data. A “trending up” flag from a model inferring insulin resistance off your sleep and skin temperature is not the same as a lab result, and treating it like one will just make you miserable for no clinical reason.
Actually get tested if: Health Guardian flags something. The entire point of a monthly trend summary is to prompt a real test, not replace one.
Google buried the better announcement behind the more expensive one. Gemini Coach got the demo, the stage time, and the $9.99-a-month price tag. Health Guardian got a blog post the same day and ships free to people who bought a Pixel Watch two generations ago. That’s a strange set of priorities for a keynote, but it’s a good outcome for anyone who already owns the hardware.
I’m not going to pretend a wrist-based model inferring metabolic strain from HRV and skin temperature is equivalent to a blood panel — it isn’t, and Google’s own disclaimers say as much. But “free, passive, and flags something worth actually getting checked” is a reasonable bar for a wellness feature to clear, and Health Guardian clears it without asking for a dollar. If you’re already wearing the hardware, there’s no real reason not to let it run in the background.
Health Guardian details reflect Google’s August 12, 2026 announcement at the Made by Google NYC event. Pixel Watch 5 and Fitbit Air pricing reflects the most recent figures published on this site as of August 2026. Insulin Resistance Trends and Blood Pressure Trends are scheduled to roll out this fall; features and availability may change before launch.